Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithms

Abstract

BackgroundThe high burden and rising incidence of cardiovascular disease (CVD) in resource constrained countries necessitates implementation of robust and pragmatic primary and secondary prevention strategies. Many current CVD management guidelines recommend absolute cardiovascular (CV) risk assessment as a clinically sound guide to preventive and treatment strategies. Development of non-laboratory based cardiovascular risk assessment algorithms enable absolute risk assessment in resource constrained countries.The objective of this review is to evaluate the performance of existing non-laboratory based CV risk assessment algorithms using the benchmarks for clinically useful CV risk assessment algorithms outlined by Cooney and colleagues.MethodsA literature search to identify non-laboratory based risk prediction algorithms was performed in MEDLINE, CINAHL, Ovid Premier Nursing Journals Plus, and PubMed databases. The identified algorithms were evaluated using the benchmarks for clinically useful cardiovascular risk assessment algorithms outlined by Cooney and colleagues.ResultsFive non-laboratory based CV risk assessment algorithms were identified. The Gaziano and Framingham algorithms met the criteria for appropriateness of statistical methods used to derive the algorithms and endpoints. The Swedish Consultation, Framingham and Gaziano algorithms demonstrated good discrimination in derivation datasets. Only the Gaziano algorithm was externally validated where it had optimal discrimination. The Gaziano and WHO algorithms had chart formats which made them simple and user friendly for clinical application.ConclusionBoth the Gaziano and Framingham non-laboratory based algorithms met most of the criteria outlined by Cooney and colleagues. External validation of the algorithms in diverse samples is needed to ascertain their performance and applicability to different populations and to enhance clinicians’ confidence in them.

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline

“…Country-and population-specific CVD risk calculators are available to quantify individual risk per local guidelines (143). However, specific cutoffs for the safe use of MHT have not been formally validated, and practice differs from country to country.…”

Circulating microRNAs predict future fatal myocardial infarction in healthy individuals – The HUNT study

“…Over the years, the knowledge of important risk factors has led to the development of several risk prediction models for determining 10-year risk of all types of cardiovascular disease (CVD) and more specifically also for acute myocardial infarction (AMI) [6][7][8][9][10][11]. However, the general use of risk prediction models has decreased in the primary care setting because current risk prediction models only explain a modest proportion of the incidence.…”

Calculadoras de riesgo cardiovascular como estrategia preventiva de eventos isquémicos en la población de Latinoamérica

“…Los resultados mostraron una alta correlación del puntaje entre la escala que utiliza exámenes de laboratorio y la que no los requiere. Así, se vuelve una alternativa factible al eliminar la necesidad de mediciones de laboratorio que incrementan el uso de recursos, mejorando la accesibilidad a un adecuado manejo de los pacientes en los países de bajos y medianos ingresos 48 . Kariuki y colaboradores realizaron una búsqueda bibliográfica para evaluar la aplicabilidad de modelos que no necesitan valores de laboratorio.…”